Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort
Kiem Oen, Ciarán M Duffy, Shirley M L Tse, Suzanne Ramsey, Janet Ellsworth, Gaëlle Chédeville, Anne-Laure Chetaille, Claire Saint-Cyr, David A Cabral, Lynn R Spiegel, Rayfel Schneider, Bianca Lang, Adam M Huber, Paul Dancey, Earl Silverman, Alan M Rosenberg, Bonnie Cameron, Nicole Johnson, Jean Dorval, Rosie Scuccimarri, Sarah Campillo, Ross E Petty, Karen N Watanabe Duffy, Gilles Boire, Elie Haddad, Kristin Houghton, Ronald Laxer, Stuart E Turvey, Paivi Miettunen, Katherine Gross, Jaime Guzman, Susanne Benseler, Brian M Feldman, Victor Espinosa, Rae S M Yeung, Lori Tucker, Kiem Oen, Ciarán M Duffy, Shirley M L Tse, Suzanne Ramsey, Janet Ellsworth, Gaëlle Chédeville, Anne-Laure Chetaille, Claire Saint-Cyr, David A Cabral, Lynn R Spiegel, Rayfel Schneider, Bianca Lang, Adam M Huber, Paul Dancey, Earl Silverman, Alan M Rosenberg, Bonnie Cameron, Nicole Johnson, Jean Dorval, Rosie Scuccimarri, Sarah Campillo, Ross E Petty, Karen N Watanabe Duffy, Gilles Boire, Elie Haddad, Kristin Houghton, Ronald Laxer, Stuart E Turvey, Paivi Miettunen, Katherine Gross, Jaime Guzman, Susanne Benseler, Brian M Feldman, Victor Espinosa, Rae S M Yeung, Lori Tucker
Abstract
Objective: To determine early outcomes and early improvements in a prospective inception cohort of children with juvenile idiopathic arthritis (JIA) treated with current standard therapies.
Methods: Patients selected were enrolled in an inception cohort of JIA, the Research in Arthritis in Canadian Children Emphasizing Outcomes Study. The juvenile rheumatoid arthritis core criteria set measures were completed at enrollment and 6 months later. Frequencies of normal values for each of the core set measures and the American College of Rheumatology (ACR) Pediatric 30, 50, and 70 (Pedi 70) criteria response rates achieved at 6 months after enrollment were calculated for each JIA-onset subtype group.
Results: Among 354 patients in the study, the median interval between diagnosis and enrollment was 0.7 months. At 6 months after enrollment, median values of active joint counts were highest in patients with rheumatoid factor (RF)-positive polyarthritis (4) and RF-negative polyarthritis (2), but were 0 or 1 for other subtypes. Fifty percent or more of patients with oligoarthritis, systemic arthritis, enthesitis-related arthritis, and undifferentiated arthritis had no active joints, and the ACR Pedi 70 criteria response rate was 48% or more in those with oligoarthritis, RF-negative polyarthritis, and systemic arthritis.
Conclusion: With current management strategies in clinical practice, improvement in disease activity was noted in considerable proportions of patients in all of the JIA subtype groups, but low levels of disease activity persisted in many. We expect that these early outcomes will prove to be significant predictors of long-term outcomes.
Source: PubMed